Latest Conference Articles

The genitourinary cancer space has seen a lot of updates in the past 5-10 years, but where are they all coming from so suddenly? Oncology Nursing News spoke with Michael Lai, ARNP, a nurse practitioner at Seattle Cancer Care Alliance, about how the genitourinary cancer space has been able to have so many updates recently.

To best help your patients, you need to understand what they are going through, and the best way to do that is to have hopeful conversations with them that get them talking.

At the 3rd Annual School of Nursing Oncology, Oncology Nursing News had the chance to sit down with Madelaine Kuiper, MSN, RN, and talk about what nurses need to understand about the evolving landscape of breast cancer treatment.

Conferences are where oncology nurses can network, discuss key topics in their field, and hear new updates that will eventually affect their patients. At the 3rd Annual School of Oncology Nursing, we had the chance to talk about what nurses can gain from these conferences with Patricia Jakel, MN, RN, AOCN.

Can combining agents turn "cold" prostate cancer tumors "hot"?

Like most other adverse events (AEs), nurses play a vital role in monitoring for and managing endocrine toxicities associated with immunotherapy treatment; however, these may be more unique than others, according to Marianne Davies, DNP, RN, CNS, ACNP-BC, AOCNP.

At the 3rd annual School of Oncology Nursing Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, presented on supportive care for GU malignancies and we had the chance to discuss the highlights with her.

Nurses should know what to look for when it comes to managing dermatologic toxicities.

Nurses can lead the healthcare team when it comes to managing immune-related GI toxicities.

Nurses must stay up to date with the fast-moving world of bladder cancer.

Treating patients with hematological malignancies has moved beyond just using chemotherapy. And to discuss this change we sat down with Laura J. Zitella, MS, RN, ACNP-BC, AOCN, associate clinical professor at the University of California San Francisco, at the 3rd annual School of Nursing Oncology.

To start, nurses must be able to prevent and anticipate GI toxicities.

Patients experiencing chemotherapy-induced nausea and vomiting (CINV) need to understand what can be done to help their symptoms, and oncology nurses can educate them on what is best to take for CINV.

There are key steps that nurses can follow to improve upon patient expectations and their understanding of end-of-life care.

Nurses must stay up to date on immunotherapy advancements, since they are the frontline communicators with patients.

At the 3rd Annual School of Nursing Oncology, we had the chance to sit down with Chasity M. Washington, MPH, CHES, director of the Center for Cancer Health Equity at The Ohio State University Comprehensive Cancer Center and discuss how to better understand each patient's unique situation.

Nurses must understand CAR T-cell therapy and be able to recognize what to do when encountering patients who have received it.

Nurses and other care providers should not assume that they know what a patient wants when it comes to expectations for their treatment.

Nurses can serve in a variety of roles when it comes to clinical trials – from being a research nurse or a vital piece of the multidisciplinary team, according to Maria Hendricks, MSN, RN.

At the 3rd annual School of Nursing Oncology (SONO) meeting, we got the chance to sit down with Madelaine Kuiper RN, MSN, and talk about what adverse events come with immune therapy for patients with breast cancer.

When nurses understand their patients' health literacy levels, as well as what kind of additional supports they need, it could lead to better drug compliance, according to one advanced practice nurse.

While the treatment landscape for lung cancer continues to grow, nurses must stay up-to-date on the most recent advances and approvals across each subgroup of patients.

To assist in treating patients with immune-related adverse events (irAEs), nurses can follow 5 pillars: prevent, anticipate, detect, treat, and monitor.

Understanding CLL is important for all oncology nurses, regardless if they specialize in hematologic or solid malignancies.

Derek Hough spoke to a crowd of oncology nurses at the 3rd Annual School of Nursing Oncology conference.

Nurses play a key role in addressing the barriers associated with patients with cancer entering a clinical trial, according to Maria Hendricks, MSN, RN.

With various FDA approvals in the last year alone, nurses must stay up-to-date on the changing treatment landscape of breast cancer to properly treat these patients.

At the 2019 Annual ASCO meeting in Chicago, Oncology Nursing News got the chance to speak with Martha Raymond, CEO and founder of the Raymond Foundation, and executive director at the GI Cancers Alliance.

With more people surviving long after their cancer diagnosis, there is also a heightened risk of developing chronic health conditions.

There is not a major difference in outcomes between whole-breast and partial-breast radiation for some patients with breast cancer.